Jose Daniel Jimenez-Santana
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jose Daniel Jimenez-Santana has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Guido Mazzinari
Department of Anesthesiology, Hospital Universitario y Politécnico La Fé, Valencia, Spain
2 shared publications - Savino Spadaro
University of Ferrara
2 shared publications Abel Guiu
Department of Anesthesiology and Pain Medicine, Hospital Universitario y Politécnico la Fe, Valencia, Spain
1 shared publicationAlejandro Gallego
Department of Anesthesiology and Pain Medicine, Hospital Universitario y Politécnico la Fe, Valencia, Spain
1 shared publication- B. Aguado Rodríguez
Médico especialista en Cirugía General, Complejo Hospitalario Universitario de Albacete, Albacete, Spain
1 shared publication - Carlo Alberto Volta
Department of Morphology, Surgery and Experimental Medicine, Section of Anaesthesia and Intensive Care, Azienda Ospedaliera-Universitaria Sant’ Anna, University of Ferrara, Ferrara, Italy
1 shared publication
Latest Publications
- 28 January 2026
- Published by Elsevier in Revista Española de Anestesiología y Reanimación (English Edition)
- Vol. 73 (2) , 501998
Practical guidance and recommendations for the safe management of the pediatric airway in anesthesia
- 28 January 2026
- Published by Elsevier in Revista Española de Anestesiología y Reanimación (English Edition)
- Vol. 73 (2) , 501998
Practical guidance and recommendations for the safe management of the pediatric airway in anesthesia
- 1 January 2026
- Published by Edizioni Minerva Medica in Minerva Anestesiologica
- Vol. 91 (12)
The impact of intravenous infusion of tramadol and ondansetron vs. epidural analgesia on the quality of recovery after cesarean section: a prospective observational trial
Optimizing post-cesarean recovery is crucial to facilitate neonatal care and improve maternal well-being. Post-cesarean neuraxial analgesia regimes are widely used, but can be resource intensive, not always feasible nor effective. Tramadol, with its dual mechanism of action and favorable safety profile, may offer an alternative. This study compared a tramadol-based continuous intravenous analgesia regimen with an epidural-based regimen with local anesthetics in terms of functional recovery and postoperative outcomes. This prospective observational cohort study was carried out in women undergoing C-sections. Patients received either continuous intravenous infusion of tramadol and ondansetron (TRON) or patient-controlled epidural analgesia with ropivacaine (EPI). Patients were consecutively enrolled until the calculated sample size for each group was reached. The primary outcome was functional recovery at 24 hours, assessed using the Quality of Recovery-15 (QoR-15) scale. Secondary outcomes included recovery over 48 hours, obstetric-specific recovery (ObsQoR-10) at 24 hours, pain scores, adverse effects, and chronic pain at 90 days. A total of 312 patients were analyzed (156 per group). QoR-15 scores were higher in TRON compared to EPI (adjusted mean difference (AMD): 8.6 [95% CI: 4.7-12.0]; P<0.001 at 24 h and 12.0 [95% CI: 5.8-15.0]; P<0.001 at 48 h). ObsQoR-10 scores also favored TRON (AMD: 13 [95% CI: 10-16]; P<0.001). Pain control was slightly better in the TRON group and adverse effects were more frequent in the EPI group. The TRON strategy offers an effective alternative for post-cesarean analgesia, with fewer side effects and easier postpartum care management. The addition of ondansetron likely played a key role.
- 1 January 2026
- Published by Edizioni Minerva Medica in Minerva Anestesiologica
- Vol. 91 (12)
The impact of intravenous infusion of tramadol and ondansetron vs. epidural analgesia on the quality of recovery after cesarean section: a prospective observational trial
Optimizing post-cesarean recovery is crucial to facilitate neonatal care and improve maternal well-being. Post-cesarean neuraxial analgesia regimes are widely used, but can be resource intensive, not always feasible nor effective. Tramadol, with its dual mechanism of action and favorable safety profile, may offer an alternative. This study compared a tramadol-based continuous intravenous analgesia regimen with an epidural-based regimen with local anesthetics in terms of functional recovery and postoperative outcomes. This prospective observational cohort study was carried out in women undergoing C-sections. Patients received either continuous intravenous infusion of tramadol and ondansetron (TRON) or patient-controlled epidural analgesia with ropivacaine (EPI). Patients were consecutively enrolled until the calculated sample size for each group was reached. The primary outcome was functional recovery at 24 hours, assessed using the Quality of Recovery-15 (QoR-15) scale. Secondary outcomes included recovery over 48 hours, obstetric-specific recovery (ObsQoR-10) at 24 hours, pain scores, adverse effects, and chronic pain at 90 days. A total of 312 patients were analyzed (156 per group). QoR-15 scores were higher in TRON compared to EPI (adjusted mean difference (AMD): 8.6 [95% CI: 4.7-12.0]; P<0.001 at 24 h and 12.0 [95% CI: 5.8-15.0]; P<0.001 at 48 h). ObsQoR-10 scores also favored TRON (AMD: 13 [95% CI: 10-16]; P<0.001). Pain control was slightly better in the TRON group and adverse effects were more frequent in the EPI group. The TRON strategy offers an effective alternative for post-cesarean analgesia, with fewer side effects and easier postpartum care management. The addition of ondansetron likely played a key role.
- Open Access
- 4 September 2024
- Published by Springer Nature in Current Anesthesiology Reports
- Vol. 14 (4) , 534-550
Current Concepts in Intraoperative Ventilation during Anesthesia for Laparoscopic and Robot–Assisted Surgery – a Narrative Review
Purpose of Review: Laparoscopic and robot–assisted procedures have become preferred over open abdominal surgery due to their numerous benefits, such as reduced postoperative pain, lower infection risk, and quicker recovery. However, these techniques pose unique challenges for intraoperative ventilation due to the need for CO2 insufflation to create a pneumoperitoneum and specific patient positioning, both of which adversely affect respiratory mechanics. This narrative review aims to summarize these challenges and describes current strategies to overcome them. Recent Findings: Implementing lung–protective ventilation with low tidal volumes and personalized PEEP, along with measures to reduce mechanical power of ventilation, have been shown to reduce postoperative pulmonary complications (PPCs). Summary: Effective and safe intraoperative ventilation during laparoscopic and robot–assisted surgery requires a nuanced understanding of respiratory mechanics and tailored ventilation strategies. Lung-protective ventilation is crucial for minimizing lung injury and optimizing patient outcomes.
- 4 September 2024
- Published by Springer Nature in Current Anesthesiology Reports
- Vol. 14 (4) , 534-550
Open AccessCurrent Concepts in Intraoperative Ventilation during Anesthesia for Laparoscopic and Robot–Assisted Surgery – a Narrative Review
Purpose of Review: Laparoscopic and robot–assisted procedures have become preferred over open abdominal surgery due to their numerous benefits, such as reduced postoperative pain, lower infection risk, and quicker recovery. However, these techniques pose unique challenges for intraoperative ventilation due to the need for CO2 insufflation to create a pneumoperitoneum and specific patient positioning, both of which adversely affect respiratory mechanics. This narrative review aims to summarize these challenges and describes current strategies to overcome them. Recent Findings: Implementing lung–protective ventilation with low tidal volumes and personalized PEEP, along with measures to reduce mechanical power of ventilation, have been shown to reduce postoperative pulmonary complications (PPCs). Summary: Effective and safe intraoperative ventilation during laparoscopic and robot–assisted surgery requires a nuanced understanding of respiratory mechanics and tailored ventilation strategies. Lung-protective ventilation is crucial for minimizing lung injury and optimizing patient outcomes.
- Open Access
- 31 August 2024
- Published by Springer Nature in Current Anesthesiology Reports
- Vol. 14 (4) , 551-566
Advanced Respiratory Monitoring in the Perioperative Setting
Purpose of Review: This narrative review explores the technical principles and evidence supporting the use of advanced respiratory monitoring tools in the perioperative setting to enhance patient care. We aim to identify which patients benefit most from these technologies during major surgeries. Recent Findings: Advanced monitoring techniques, such as electrical impedance tomography (EIT), esophageal pressure (Pes) monitoring, and lung ultrasound (LUS), provide detailed insights into lung mechanics and function. Recent studies indicate these tools can optimize ventilation strategies by individualizing the lung protective ventilation, particularly in high-risk patients. Summary: While these tools can help to improve intraoperative respiratory mechanics and oxygenation, further randomized clinical trials are needed to confirm their impact on patient-centered outcomes.
- 31 August 2024
- Published by Springer Nature in Current Anesthesiology Reports
- Vol. 14 (4) , 551-566
Open AccessAdvanced Respiratory Monitoring in the Perioperative Setting
Purpose of Review: This narrative review explores the technical principles and evidence supporting the use of advanced respiratory monitoring tools in the perioperative setting to enhance patient care. We aim to identify which patients benefit most from these technologies during major surgeries. Recent Findings: Advanced monitoring techniques, such as electrical impedance tomography (EIT), esophageal pressure (Pes) monitoring, and lung ultrasound (LUS), provide detailed insights into lung mechanics and function. Recent studies indicate these tools can optimize ventilation strategies by individualizing the lung protective ventilation, particularly in high-risk patients. Summary: While these tools can help to improve intraoperative respiratory mechanics and oxygenation, further randomized clinical trials are needed to confirm their impact on patient-centered outcomes.
- Open Access
- 5 January 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (2) , 317
Prone Positioning and Molecular Biomarkers in COVID and Non-COVID ARDS: A Narrative Review
Prone positioning (PP) represents a therapeutic intervention with the proven capacity of ameliorating gas exchanges and ventilatory mechanics indicated in acute respiratory distress syndrome (ARDS). When PP is selectively applied to moderate-severe cases of ARDS, it sensitively affects clinical outcomes, including mortality. After the COVID-19 outbreak, clinical application of PP peaked worldwide and was applied in 60% of treated cases, according to large reports. Research on this topic has revealed many physiological underpinnings of PP, focusing on regional ventilation redistribution and the reduction of parenchymal stress and strain. However, there is a lack of evidence on biomarkers behavior in different phases and phenotypes of ARDS. Patients response to PP are, to date, decided on PaO2/FiO2 ratio improvement, whereas scarce data exist on biomarker tracking during PP. The purpose of this review is to explore current evidence on the clinical relevance of biomarkers in the setting of moderate-severe ARDS of different etiologies (i.e., COVID and non-COVID-related ARDS). Moreover, this review focuses on how PP may modulate biomarkers and which biomarkers may have a role in outcome prediction in ARDS patients.
- 5 January 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (2) , 317
Open AccessProne Positioning and Molecular Biomarkers in COVID and Non-COVID ARDS: A Narrative Review
Prone positioning (PP) represents a therapeutic intervention with the proven capacity of ameliorating gas exchanges and ventilatory mechanics indicated in acute respiratory distress syndrome (ARDS). When PP is selectively applied to moderate-severe cases of ARDS, it sensitively affects clinical outcomes, including mortality. After the COVID-19 outbreak, clinical application of PP peaked worldwide and was applied in 60% of treated cases, according to large reports. Research on this topic has revealed many physiological underpinnings of PP, focusing on regional ventilation redistribution and the reduction of parenchymal stress and strain. However, there is a lack of evidence on biomarkers behavior in different phases and phenotypes of ARDS. Patients response to PP are, to date, decided on PaO2/FiO2 ratio improvement, whereas scarce data exist on biomarker tracking during PP. The purpose of this review is to explore current evidence on the clinical relevance of biomarkers in the setting of moderate-severe ARDS of different etiologies (i.e., COVID and non-COVID-related ARDS). Moreover, this review focuses on how PP may modulate biomarkers and which biomarkers may have a role in outcome prediction in ARDS patients.